Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Hum Pathol. 2021 Aug 18;117:88–100. doi: 10.1016/j.humpath.2021.08.004

Table 2.

Performance characteristics for SSTR2 in various virus-positive and negative head and neck squamous cell carcinomas

Tumor type (n=number of patients) SSTR2 Positive (%)
EBV-positive NPC (n=9) 8/9 (89%)
EBV-negative undifferentiated/non-keratinizing NPC (n=1) 1/1 (100%)
HPV-positive sinonasal carcinoma (n=11) 1/11 (9%)
HPV-negative sinonasal carcinoma (n=9) 0/9 (0%)
HPV-positive oropharyngeal carcinoma (n=10) 0/10 (0%)
Virus-negative SCC of oral cavity and tongue (n=2) 0/2 (0%)

Abbreviation: NPC-nasopharyngeal carcinoma, SCC-squamous cell carcinoma, EBV-Epstein-Barr Virus, HPV-human papilloma virus, SSTR2-somatostain receptor 2